Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (141) clinical trials

Are you living with Multiple Sclerosis? Have you experienced a worsening of your MS symptoms or the onset of new symptoms in the last two years? If so, you may qualify for a research study. NeuroTrials Research is conducting a 96 week, non-placebo, comparative trial to determine whether an investigational ...

Phase

Winthrop University Hospital is conducting a study for people with Primary Progressive MS and whom are willing to take an investigational medication intravenously. The purpose of this study is to determine the effectiveness and safety of an investigational medication for the treatment of Primary Progressive MS. Patient Inclusion Criteria: To ...

Phase

A Voluntary Research Study is currently being conducted to evaluate different medications that treat relapsing remitting forms of multiple sclerosis (MS). You may qualify to participate in this voluntary research study if you: Are between the ages of 18 and 65 years old. Have been diagnosed with a relapsing remitting ...

Phase

Patient Inclusion Criteria: Ages 18-70 21 Day Washout of all spasticity medications Has multiple sclerosis (MS) based on Poser or McDonald Criteria (all subtypes of MS will be accepted, including relapsing remitting, primary or secondary progressive, if disease is stable per exclusion criteria). Expanded Disability Status Scale (EDSS) rating between ...

Phase

Patient Inclusion Criteria: Ages 18-60 SPMS diagnosis Must be able to walk Diagnosed with MS as defined by the modified McDonald criteria SPMS defined as relapsing-remitting disease with recent progression in MS-related neurological deficits EDSS score 3.0 - 6.0, inclusively Presence of myelin reactive T-cells Patient Exclusion Criteria: Diagnosed with ...

Phase

Patient Inclusion Criteria: Ages 18-65 No MS relapses required for study entry Written informed consent must be obtained prior to any assessment being performed. Male and female patients aged 18-65 years inclusive. Patients diagnosed with relapsing remitting MS, defined by the 2010 revised McDonald criteria EDSS score of less than ...

Phase

Patient Inclusion Criteria: Ages 18-65 1 Relapse in Past Year/2 Relapses in Past 2 years No Assistive Device to Walk/Use Cane but can walk 500 meters with C Written informed consent must be obtained before any assessment is performed Male and female patients 18 to 65 years of age, inclusive. ...

Phase

The purpose of the study is to determine if risk factors identified for adult multiple sclerosis are also risk factors for pediatric MS, and if there are interactions between. There is 1 study visit to St. Louis Children’s Hospital.

Phase N/A

Do you have multiple sclerosis? Meridien Research is seeking research volunteers for a clinical study of an oral MS medication.

Phase N/A

Meridien Research is conducting a new research study for the treatment of Secondary Progressive Multiple Sclerosis utilizing the investigational medication, Tcelna©, a personalized immunotherapy manufactured for individual patients.

Phase N/A